Who
Jean Bennett
Director
Company insider
Files Form 4 as: Director, Regenxbio; Director, Opus Genetics.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Sep 2021
- Last trade
- 29 May 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 May 2026filed 2 Jun 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —9,807 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —46,600 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —46,600 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —9,807 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —24,367 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —24,367 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —21,127 | filing |
| 1 Jan 2026filed 5 Jan 2026 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —21,127 | filing |
| 30 May 2025filed 3 Jun 2025 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —39,815 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —7,768 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | IRD Opus Geneticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,592 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —79,504 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —34,021 | filing |
| 22 Oct 2024filed 24 Oct 2024 | IRD Opus Geneticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —172,874 at $0.00 | filing |
| 22 Oct 2024filed 24 Oct 2024 | IRD Opus GeneticsBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 31 May 2024filed 4 Jun 2024 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —24,454 at $0.00 | filing |
| 31 May 2024filed 4 Jun 2024 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —4,790 at $0.00 | filing |
| 2 Jun 2023filed 6 Jun 2023 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —17,892 at $0.00 | filing |
| 2 Jun 2023filed 6 Jun 2023 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —3,486 at $0.00 | filing |
| 3 Jun 2022filed 7 Jun 2022 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —15,324 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.